BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1110869)

  • 1. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
    Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
    Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcysteine in the oral mucolytic treatment of cystic fibrosis.
    Stephan U; Böwing B; Goering U; Wiesemann HG; Reinhardt M; Hirche H; Brandt H
    Eur J Respir Dis Suppl; 1980; 111():127-31. PubMed ID: 6938396
    [No Abstract]   [Full Text] [Related]  

  • 3. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
    Mateos-Corral D; Cutz E; Solomon M; Ratjen F
    Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
    Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mucolytic agents for inhalation].
    Rocchietta S
    Boll Chim Farm; 1970 Dec; 109(12):727. PubMed ID: 5521483
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of positive expiratory pressure *PEP* in cystic fibrosis patient inhalations.
    Orlik T; Sands D
    Dev Period Med; 2015; 19(1):50-9. PubMed ID: 26003070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffered L-arginine as treatment of cystic fibrosis: state of the evidence.
    Graham GG; Solomons CC
    Pediatrics; 1972 Mar; 49(3):471-2. PubMed ID: 5062272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with oral N-acetyl-cysteine treatment in children suffering from cystic fibrosis (author's transl)].
    Dietzsch HJ; Berger G; Gottschalk B; Leupold W; Mittenzwey KW; Rupprecht E; Wunderlich P
    Z Erkr Atmungsorgane; 1980; 155(1):109-13. PubMed ID: 7210734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis.
    App EM; Baran D; Dab I; Malfroot A; Coffiner M; Vanderbist F; King M
    Eur Respir J; 2002 Feb; 19(2):294-302. PubMed ID: 11866009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral acetylcysteine in cystic fibrosis. A co-operative study.
    Götz M; Kraemer R; Kerrebijn KF; Popow C
    Eur J Respir Dis Suppl; 1980; 111():122-6. PubMed ID: 7011832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhalations with L-arginine in the treatment of cystic fibrosis (author's transl)].
    Busch-Petersen D; Hein J; Güloz HU
    Z Erkr Atmungsorgane; 1975 May; 143(2):140-7. PubMed ID: 1224683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of N-acetylcysteine in cystic fibrosis.
    Duijvestijn YC; Brand PL
    Acta Paediatr; 1999 Jan; 88(1):38-41. PubMed ID: 10090545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of bronchology in the long-term treatment of mucoviscidosis in children].
    Dietzsch HJ; Berger G; Gottschalk B; Händel D; Heyne K; Wunderlich P
    Bronches; 1970; 20(6):383-96. PubMed ID: 5519295
    [No Abstract]   [Full Text] [Related]  

  • 15. CLINICAL EVALUATION OF ACETYLCYSTEINE AS A MUCOLYTIC AGENT IN CYSTIC FIBROSIS.
    STAMM SJ; DOCTER J
    Dis Chest; 1965 Apr; 47():414-20. PubMed ID: 14272541
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine in cystic fibrosis. Mechanical and chemical factors in treatment by aerosol.
    Denton R; Kwart H; Litt M
    Am Rev Respir Dis; 1967 Apr; 95(4):643-51. PubMed ID: 6021126
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro and in vivo effect of various substances on the viscosity of sputum from patients with cystic fibrosis].
    Mastella G; Marcer V; Battaglino G
    Fracastoro; 1970; 63(3):479-507. PubMed ID: 5517025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.